Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group. Black DM, et al. Among authors: wehren le. JAMA. 2006 Dec 27;296(24):2927-38. doi: 10.1001/jama.296.24.2927. JAMA. 2006. PMID: 17190893 Clinical Trial.
Osteoporosis and fracture risk in women of different ethnic groups.
Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, Santora AC, Sherwood LM. Barrett-Connor E, et al. Among authors: wehren le. J Bone Miner Res. 2005 Feb;20(2):185-94. doi: 10.1359/JBMR.041007. Epub 2004 Oct 18. J Bone Miner Res. 2005. PMID: 15647811 Free article.
Hip fracture: risk factors and outcomes.
Wehren LE, Magaziner J. Wehren LE, et al. Curr Osteoporos Rep. 2003 Sep;1(2):78-85. doi: 10.1007/s11914-003-0013-8. Curr Osteoporos Rep. 2003. PMID: 16036069 Review.
31 results